J&J and Sientra get FDA warning letters for breast implants

Indonesia Berita Berita

J&J and Sientra get FDA warning letters for breast implants
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 Reuters
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

The U.S. Food and Drug Administration has issued warning letters to Sientra Inc ...

- The U.S. Food and Drug Administration has issued warning letters to Sientra Inc and a Johnson & Johnson unit for failing to comply with the post-approval study requirements for their breast implants.

The agency’s letters, dated March 18, highlighted issues in the companies’ post-approval studies, which included evaluating the long-term performance and safety of the implants, used for breast augmentation and reconstruction procedures. Sientra had reported poor patient follow-up rate of 61 percent for the post-approval study of its Silicone Gel Breast Implants, which required the company to evaluate the study subjects annually for 10 years, according to the FDA letter.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Reuters /  🏆 2. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Kind bars wants the FDA to change how it regulates food labelsKind bars wants the FDA to change how it regulates food labelsKind, the maker of the popular nut bars, filed a petition Wednesday asking the FDA to change how it regulates claims on food labels.
Baca lebih lajut »

U.S. proposes stricter curbs on e-cigarette salesU.S. proposes stricter curbs on e-cigarette salesThe U.S. Food and Drug Administration (FDA) on Wednesday released formal plans t...
Baca lebih lajut »

FDA tightens restrictions on e-cigarette sales and fruity flavors to stem teen vapingFDA tightens restrictions on e-cigarette sales and fruity flavors to stem teen vapingFDA tightens restrictions on e-cigarette sales and fruity flavors to stem teen vaping.
Baca lebih lajut »

FDA puts partial hold on clinical trials of AbbVie's cancer drugFDA puts partial hold on clinical trials of AbbVie's cancer drugAbbVie Inc said on Tuesday the U.S. Food and Drug Administration placed a partia...
Baca lebih lajut »

FDA considers yanking nicotine vaping pods off the marketFDA considers yanking nicotine vaping pods off the marketU.S. Food and Drug Administration Commissioner Scott Gottlieb said Tuesday that his agency may need to pull pod-based nicotine products off the market as it fights a surge in teen vaping.
Baca lebih lajut »

FDA outlines e-cigarette rules, tightens restrictions on fruity flavors to try to curb teen vapingFDA outlines e-cigarette rules, tightens restrictions on fruity flavors to try to curb teen vapingOutgoing FDA chief Scott Gottlieb released the agency's much-anticipated draft rules restricting e-cigarette sales, tightening sales and eventually remove from the market many of the fruity flavors he's blamed on fueling an 'epidemic' of teen use.
Baca lebih lajut »

FDA Sets Limits on Retail Sales of Flavored E-CigarettesFDA Sets Limits on Retail Sales of Flavored E-CigarettesConvenience stores and gas stations will effectively be banned from selling most flavored e-cigarettes under restrictions issued by the Food and Drug Administration.
Baca lebih lajut »

FDA rolls out vaping policy to make it harder for minors to buy flavored productsFDA rolls out vaping policy to make it harder for minors to buy flavored productsThe Food and Drug Administration, responding to the surge in underage vaping, on Wednesday issued a much-anticipated policy designed to make it harder for young people to acquire many types of e-cigarettes.
Baca lebih lajut »



Render Time: 2025-03-27 07:59:32